Vascular smooth muscle cells sense calcium: A new paradigm in vascular calcification

Cardiovascular Research

Volumn 81, Issue 2, 2009, Pages 237-239

  Touyz, Rhian M ^a   Montezano, Augusto C ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CALCIUM; CALCIUM PHOSPHATE; CALCIUM SENSING RECEPTOR; FETUIN A; OSTEOGENIC PROTEIN 1; OSTEOPONTIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; SMAD PROTEIN; SMAD6 PROTEIN; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

BLOOD VESSEL CALCIFICATION; BONE MINERALIZATION; CALCIUM HOMEOSTASIS; CARDIOVASCULAR RISK; EDITORIAL; EXTRACELLULAR CALCIUM; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANIMALS; CALCINOSIS; CALCIUM; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, CALCIUM-SENSING;

EID: 58449129673     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn345     Document Type: Editorial

References (15)

1. Guzman RJ. Clinical, Cellular, and molecular aspects of arterial calcification. J Vasc Surg 2007;45(Suppl. A):A57-A63.
2. London GM, Marchais SJ, Guérin AP, Métivier F. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 2005;14:525-531.
3. Cozzolino M, Mazzaferro S, Pugliese F, Brancaccio D. Vascular calcification and uremia: what do we know? Am J Nephrol 2008;28:339-346.
4. Weissen-Plenz G, Nitschke Y, Rutsch F. Mechanisms of arterial calcification: spotlight on the inhibitors. Adv Clin Chem 2008;46:263-293.
5. Moe SM, Reslerova M, Ketteler M, O'Neill K, Duan D, Koczman J et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005;67:2295-2304.
6. Schoppet M, Shroff RC, Hofbauer LC, Shanahan CM. Exploring the biology of vascular calcification in chronic kidney disease: what's circulating? Kidney Int 2008;73:384-390.
7. Griethe W, Schmitt R, Jurgensen JS, Bachmann S, Eckardt KU, Schindler R. Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis. J Nephrol 2003;16:728-732.
8. Suliman ME, García-López E, Anderstam B, Lindholm B, Stenvinkel P. Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease. Adv Clin Chem 2008;46:217-262.
9. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007;116:85-97.
10. Alam M, Kirton JP, Wilkinson FL, Towers E, Sinha S, Rouhi M et al. Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells. Cardiovasc Res. 2009;81:260-268.
11. Yamaguchi T. The calcium-sensing receptor in bone. J Bone Miner Metab 2008;26:301-311.
12. Egbuna OI, Brown EM. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol 2008;22:129-148.
13. Molostvov G, James S, Fletcher S, Bennett J, Lehnert H, Bland R, Zehnder D. Extracellular calcium-sensing receptor is functionally expressed in human artery. Am J Physiol Renal Physiol 2007;293:F946-F955.
14. Fryer RM, Segreti JA, Widomski DL, Franklin PH, Banfor PN, Koch KA et al. Systemic activation of the calcium sensing receptor produces acute effects on vascular tone and circulatory function in uremic and normal rats: focus on central versus peripheral control of vascular tone and blood pressure by cinacalcet. J Pharmacol Exp Ther 2007;323:217-226.
15. Weston AH, Absi M, Harno E, Geraghty AR, Ward DT, Ruat M et al. The expression and function of Ca(2 +)-sensing receptors in rat mesenteric artery; comparative studies using a model of type II diabetes. Br J Pharmacol 2008;154:652-662.